In this episode, Dr. Harold Bays and Dr. Carolynn Francavilla discuss their experience with prior authorizations for obesity medications including the highly effective GLP-1 medications.
In episode three of our four-part Advocacy series, Dr. Nicholas Pennings, an Obesity Medicine Specialist and Clinical Education Director at OMA, engages in a...
In this episode, OMA Executive Director of Clinical Education, Dr. Nicholas Pennings is joined by Dr. Ethan Lazarus, 2021-2022 President of the OMA Board...
Episode Description In this episode, the OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM interviews Craig Primack, MD, FACP, FAAP, FOMA, Dipl....